Securities code: Hybio Pharmaceutical Co.Ltd(300199) securities abbreviation: Hybio Pharmaceutical Co.Ltd(300199) Announcement No.: 2022036 Hybio Pharmaceutical Co.Ltd(300199)
Notice on convening the first extraordinary general meeting of shareholders in 2022
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
Hybio Pharmaceutical Co.Ltd(300199) (hereinafter referred to as "the company" or " Hybio Pharmaceutical Co.Ltd(300199) ") held the fifth meeting of the Fifth Board of directors on March 24, 2022, deliberated and adopted the proposal on proposing to convene the first extraordinary general meeting of shareholders in 2022. The relevant matters of the first extraordinary general meeting of shareholders in 2022 are hereby notified as follows:
1、 Basic information of the meeting
1. Session of the general meeting of shareholders: the first extraordinary general meeting of shareholders in 2022
2. Convener: Board of directors
3. The 5th meeting of the 5th board of directors of the company agreed to convene this general meeting of shareholders. The convening of this meeting complies with the provisions of relevant laws, administrative regulations, normative documents and the articles of association.
4. Meeting mode: this meeting adopts the combination of on-site voting and online voting. The company will use the trading system of Shenzhen Stock Exchange and Internet voting system（ http://wltp.cn.info.com.cn. ）Provide all shareholders with a voting platform in the form of network, and the shareholders of the company can exercise their voting rights through the above system during the online voting time.
5. Meeting time:
(1) On site meeting time: 15:30 p.m. on Monday, April 11, 2022.
(2) Online voting time:
The specific time of online voting through the trading system of Shenzhen stock exchange is: 9:15-9:25 a.m., 9:30-11:30 p.m. and 13:00-15:00 p.m. on April 11, 2022.
The specific time of voting through the Internet voting system of Shenzhen stock exchange is any time from 9:15 a.m. on April 11, 2022 to 15:00 p.m. on April 11, 2022.
6. Equity registration date: Wednesday, April 6, 2022.
7. Attendees:
If a proxy is entrusted to attend the meeting and vote in person, the proxy need not be a shareholder of the company.
(2) Relevant directors, supervisors and senior managers of the company.
(3) Witness lawyer employed by the company.
8. Venue: conference room on the first floor of Hybio Pharmaceutical Co.Ltd(300199) office building, No. 37, kekekezhong Second Road, high tech Industrial Park, Nanshan District, Shenzhen.
9. Way of attending the meeting: the same share can only choose one of on-site voting and online voting, and the voting result shall be subject to the first valid voting result.
2、 Matters considered at the meeting
remarks
Proposal code proposal name the ticked column can vote
100 total proposal √
Non cumulative voting proposal
1.00 about the company's 2022 restricted stock incentive plan (Draft) and its summary √
Motion
2.00 management measures for the implementation and assessment of the company's restricted stock incentive plan in 2022 √
Motion
3.00 about requesting the general meeting of shareholders to authorize the board of directors to handle the restricted stock incentive in 2022 √
Proposal on matters related to the plan
4.00 proposal on directional financing from Shenzhen hi tech investment and Financing Guarantee Co., Ltd. √
The above proposals have been deliberated and adopted at the fifth meeting of the Fifth Board of directors and the fourth meeting of the Fifth Board of supervisors held on March 24, 2022. For details, please refer to www.cn.info.com.cn. On March 25, 2022 Relevant announcements on.
The above proposals are special resolutions, which need to be passed by more than 2 / 3 of the voting rights held by the shareholders (including the shareholder representative) attending the general meeting of shareholders. All incentive objects and their related parties to be granted by the company's equity incentive plan are related shareholders and need to avoid voting.
The independent directors of the company solicited voting rights from all shareholders on the above proposal. For the specific contents of soliciting voting rights, see the report on public solicitation of entrusted voting rights by independent directors disclosed on cninfo.com on the same day.
The proposal of this general meeting of shareholders requires separate vote counting for the voting of small and medium-sized investors (small and medium-sized investors refer to other shareholders except directors, supervisors, senior managers and shareholders who individually or jointly hold more than 5% of the shares of the listed company).
1. Registration method
(1) Natural person shareholders shall go through the registration procedures with their own ID card and shareholder account card; If an agent is entrusted to attend the meeting, he shall go through the registration formalities with the agent's ID card, power of attorney (Annex III), the principal's shareholder account card and the principal's ID card.
(2) The legal representative or the agent entrusted by the legal representative shall attend the meeting. If the legal representative attends the meeting, he shall go through the registration formalities with the shareholder's account card, the copy of the business license stamped with the official seal, the certificate of the legal representative and the ID card; If the legal representative entrusts an agent to attend the meeting, the agent shall go through the registration formalities with the agent's ID card, a copy of the business license stamped with the official seal, the power of attorney issued by the legal representative (Annex III), the certificate of the legal representative and the stock account card of the legal person shareholder.
(3) Shareholders can register by letter or fax. Shareholders should carefully fill in the registration form of shareholders attending the meeting (Annex II) and submit it to the company together with the above registration documents, and be sure to bring the original of the above materials and submit them to the company when attending the on-site meeting for registration confirmation.
(4) Telephone registration is not accepted for this meeting.
2. Registration time: the on-site registration time of this general meeting of shareholders is Friday, April 8, 2022 (9:00-12:00 a.m.; 13:00-17:00 p.m.); For registration by letter or fax, the letter or fax received by the company before 17:00 on Friday, April 8, 2022 shall prevail.
3. Registration place and mailing address of the letter: Hybio Pharmaceutical Co.Ltd(300199) securities management department (room 510, Hybio Pharmaceutical Co.Ltd(300199) office building, No. 37, kekekezhong Second Road, Middle District, high tech Industrial Park, Nanshan District, Shenzhen). If the registration is made by letter, please indicate the words "general meeting of shareholders" on the envelope; Postal Code: 518057; Mail: hy@hyb io. com. cn.。
4. Note: shareholders and shareholders' agents attending the on-site meeting should bring the original of relevant certificates and go through the registration formalities at the venue half an hour before the meeting.
4、 Specific operation process of participating in online voting
At this shareholders' meeting, shareholders can vote through the trading system and Internet voting system of Shenzhen Stock Exchange (address: http: / / wltp. CN. Info. Com. CN.) See Annex I for the specific operation process of voting and online voting.
5、 Other matters
1. Contact information
Contact: Yang Di
Contact address: No.37 kekekezhong 2nd Road, high tech Industrial Park, Nanshan District, Shenzhen Hybio Pharmaceutical Co.Ltd(300199) securities management department
Tel.: 075526588036; Mail: [email protected]. ； Postal Code: 5180572. The duration of this meeting is expected to be half a day, and the accommodation and transportation expenses of the participants shall be borne by themselves. 6、 Documents for future reference 1. Announcement on the resolution of the 5th meeting of the Hybio Pharmaceutical Co.Ltd(300199) 5th board of directors 2. Announcement on the resolution of the 4th meeting of the Hybio Pharmaceutical Co.Ltd(300199) 5th board of supervisors 3. Other documents required by Shenzhen Stock Exchange are hereby announced.
Hybio Pharmaceutical Co.Ltd(300199) board of directors March 25, 2022 Annex I: specific operation process of participating in online voting Annex II: registration form of participating shareholders Annex III: power of attorney
Annex I:
Specific operation process of participating in online voting
I Procedures for online voting
1. Voting code: 350199, voting abbreviation: "Hanyu voting".
2. Fill in the voting opinions or election votes
The proposal of the general meeting of shareholders is a non cumulative voting proposal, and the voting opinions are filled in: agree, disagree and abstain. 3. When shareholders vote on the general proposal, they are deemed to express the same opinions on all proposals except the cumulative voting proposal.
When shareholders vote repeatedly on the general proposal and specific proposal, the first valid vote shall prevail. If the shareholder votes on the specific proposal first and then on the general proposal, the voting opinion of the specific proposal that has been voted shall prevail, and the voting opinion of the general proposal shall prevail for other proposals that have not been voted; If the general proposal is voted first and then the specific proposal is voted, the voting opinion of the general proposal shall prevail.
II Procedures for voting through the trading system of Shenzhen Stock Exchange
1. Voting time: trading time on April 11, 2022, i.e. 9:15-9:25, 9:30-11:30 and 13:00-15:00.
2. Shareholders can log in to the trading client of the securities company and vote through the trading system.
III Procedures for voting through the Internet voting system of Shenzhen Stock Exchange
1. The Internet voting system starts at 9:15 a.m. on April 11, 2022 (the day of the on-site general meeting) and ends at 15:00 p.m. on April 11, 2022 (the day of the on-site general meeting).
2. For online voting through the Internet voting system, shareholders need to handle identity authentication in accordance with the provisions of the guidelines for online investor service identity authentication business of Shenzhen Stock Exchange (revised in April 2016) and obtain the "Shenzhen stock exchange digital certificate" or "Shenzhen Stock Exchange investor service password". The specific identity authentication process can log in to the Internet voting system http://wltp.cn.info.com.cn. Refer to the rule guidance column.
3. According to the service password or digital certificate obtained, shareholders can log in to the Internet voting system of Shenzhen Stock Exchange http://wltp.cn.info.com.cn. Vote through the system within the specified time.
Annex II:
Registration form of shareholders attending the meeting
Status
Shareholder Certificate No
Code / Battalion
Name: ye Zhi
Photo number
Shareholding of shareholders
Number of accounts
Card number
Contact contact
Telephone address
Electronic zip code
Mail Yes No
My remarks
Attend the meeting
Annex III:
Power of attorney
I hereby entrust Mr. (Ms.) to attend the first extraordinary general meeting of shareholders in Hybio Pharmaceutical Co.Ltd(300199) 2022 on behalf of me / the company and exercise voting rights on my behalf. The details are as follows:
Tick the name of the proposal in the remarks column to indicate the voting right to reject the proposal
100 total proposal √
Non cumulative voting proposal
1.00 about the company's 2022 restricted stock incentive plan (Draft) √
And its summary
2.00 assessment on the implementation of the company's restricted stock incentive plan in 2022 √
Management measures
3.00 about requesting the general meeting of shareholders to authorize the board of directors to handle the restrictions in 2022 √
